RHOA and pulmonary arterial hypertension: Activation of RhoA/ROCK inhibits MLC phosphatase and maintains MLC phosphorylation at low [Ca2+]c, thus promoting Ca2+ sensitization, sustained vasoconstriction, increased pulmonary vascular resistance, and PAH [377].